What Happened
BrainChip, the Melbourne-founded neuromorphic computing company listed on the ASX, told a briefing on Friday that a medical partner has used its chip inside a pair of glasses to track eye movement and predict epileptic seizures an hour in advance with 98 per cent accuracy.
Chief executive Sean Hehir described the company's founding purpose in plain terms: "This company, founded on a vision from two founders, was about mimicking the human brain, which is the most efficient computational engine on the planet."
The chip is designed to stay dormant until a stimulus, whether sound, sight or another sensor input, activates it. That architecture keeps power consumption low, a property Hehir said distinguishes BrainChip from conventional chip makers. "There is virtually nobody in this market who can do the things that we can do," he said.
BrainChip reported a net loss of $US12 million (A$17 million) for the half year ended 30 June 2026, compared with a $US9.4 million (A$13.1 million) loss in the same period a year earlier. Shares were changing hands at about 13.5 cents on Friday afternoon, down 3.6 per cent on the day, though the stock has traded as high as 27 cents over the past twelve months.
Why It Matters
The epilepsy application illustrates a concrete clinical consequence of the technology. Hehir noted that people living with epilepsy have historically avoided driving out of fear of an unexpected seizure. "In the past, people with epilepsy ... were afraid to drive because they were concerned about having a seizure," he said. "This creates a whole potential freedom of life."
Beyond medicine, Hehir pointed to defence as a second major target. "The defence world has changed dramatically ... in a defence situation, you cannot afford to lose a network," he said. The chip's low-power, always-on sensing capability is relevant to edge deployments where network connectivity cannot be guaranteed.
The broader context for Australian AI hardware development is complicated. The factPoolRef notes that the build-out of data centres in Australia has been slowed by legislation, community opposition and the large energy requirements involved, factors that make low-power edge chips a practical alternative for some applications.
Key Details
BrainChip's chip is neuromorphic, meaning its architecture is modelled on the way biological neurons fire in response to stimuli rather than running continuous computations. The device sits dormant and draws minimal power until an input triggers it.
Hehir was explicit that BrainChip is not positioning itself against Nvidia, the world's largest company by market capitalisation, in the race for the most powerful chips. The company's stated aim is efficiency at the edge, not raw throughput in a data centre.
The glasses-based epilepsy device tracks eye movement to detect pre-seizure patterns. The 98 per cent advance-prediction accuracy, achieved an hour before a seizure, is the figure Hehir cited at Friday's briefing.
Background and Context
BrainChip was founded on the concept of replicating the human brain's computational efficiency in silicon. Neuromorphic chips have attracted research interest globally for years, but commercial deployments remain limited. The ABC reported in March 2025 on Cortical Labs, another Australian company working on neuron-based computing, illustrating that Australia has more than one firm pursuing brain-inspired hardware approaches.
BrainChip's ASX listing gives it a public market profile uncommon among neuromorphic chip developers worldwide. Its losses are widening as it invests in commercialisation, a pattern typical of hardware startups moving from research to product.
What Comes Next
Hehir framed the current moment as critical for the company's trajectory. "This opportunity is the largest I have seen in my life ... we need to run at it with speed," he said. The company is pursuing both the medical device market, where the epilepsy glasses represent one example, and defence contracts where edge-computing resilience is a stated requirement.
No specific product launch dates or contract values were disclosed at the Friday briefing, based on the available sourced material.